Basilea Bids Farewell To Oncology To Focus On Anti-Infectives

Puts Faith In US Approval Of Antibiotic Zevtera

 
• By Kevin Grogan
  
severing ties and boycott concept
Basilea cutting off its cancer assets • Source: Archive

More from Strategy

More from Business